what are the side effects of glp 1 drugs long term glp-1 GLP-1 medications, commonly used for type 2 diabetes what are the side effects

The glp-1 agonists market is expected to reach US$ 118,926.1 billion by 2032, growing at a significant CAGR of 18.1% from 2026 to 2032.

Overall, the EASD-ADA consensus provides a dynamic framework that supports a multifaceted, patient-centric approach to type 2 diabetes care, aiming to reduce complications, improve quality of life, and promote long-term health outcomes

New data is illuminating the full profile of GLP-1 side effects

DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006

The best results happen when the medicine is used along with healthy eating and exercise, and people may gain weight back if they stop taking the medicine